Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion type Assertion NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_head.
- NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion description "[In this explorative study, interleukin-1 (IL-1) receptor antagonist (IL-1RA; polymorphism of variable number of tandem repeats: VNTR), IL-1alpha (-889), IL-1beta (-511) and IL-1beta (+3953) polymorphisms were studied in relation to susceptibility to and severity of multiple sclerosis (MS), in 93 MS patients and 400 normal controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_provenance.
- NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion evidence source_evidence_literature NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_provenance.
- NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion SIO_000772 11311293 NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_provenance.
- NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion wasDerivedFrom befree-20150227 NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_provenance.
- NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_assertion wasGeneratedBy ECO_0000203 NP491318.RAT0HTxy2GM0WEVxMpPFMmK-i5iEJAhyQcuh2ihmQKi-o130_provenance.